Jim Cramer's Stop Trading: InterMune Is for Real

NEW YORK (TheStreet) -- InterMune (ITMN) "had an amazing move" and is now stabilizing, according to TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio.

Speaking during CNBC's "Cramer's Stop Trading" segment, he said there is a "very good analyst" at R.W. Baird named Brian Skorney who is "writing very positive things."

He added that investors were initially very optimistic on the prospects of the company's pulmonary fibrosis treatment. 

Phase III results are due out soon and Cramer suggested that "there is going to be fireworks" if the company has positive news about the drug to announce at the American Thoracic Society's annual meeting. 

Although biotech stocks have been out of favor among investors, "I think InterMune is for real," Cramer concluded.

-- Written by Bret Kenwell in Petoskey, Mich.

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.

More from Opinion

It's Just Not Smart For Investors to Ignore the Threat of a Trade War

It's Just Not Smart For Investors to Ignore the Threat of a Trade War

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

To Think a Trade War's Still Just a Threat Is the Dumbest Thing on Wall Street

Flashback Friday in Politics: Trade Wars, Manafort, Immigration Dominate Minds

Flashback Friday in Politics: Trade Wars, Manafort, Immigration Dominate Minds

Microsoft and Sony's Rumored Game Console Plans Bode Well for AMD

Microsoft and Sony's Rumored Game Console Plans Bode Well for AMD

Apple Supplier Jabil Is Tumbling, But Its Sales Momentum Remains Strong

Apple Supplier Jabil Is Tumbling, But Its Sales Momentum Remains Strong